Advertisement
News
Advertisement

Forma collaborating with Eisai in $20M+ deal

Wed, 11/17/2010 - 11:38am
Mass High Tech: The Journal of New England Technology

Cambridge small-molecule therapeutics developer Forma Therapeutics Inc. has signed a drug discovery collaboration agreement with Eisai Inc., the U.S. subsidiary of Tokyo pharmaceutical firm Eisai Co. Ltd.

As part of the deal, Forma will receive $20 million in upfront payments and funding from Eisai, as well as future milestone payments and royalties on products developed by Eisai that stem from the Forma collaboration.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading